• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同年龄段中国儿童单次静脉注射丙泊酚的药代动力学

Pharmacokinetics of a single bolus of propofol in chinese children of different ages.

作者信息

Shangguan Wang Ning, Lian QingQuan, Aarons Leon, Matthews Ivan, Wang Zengshou, Chen Xiaolin, Freemantle Nick, Smith Fang Gao

机构信息

Department of Anesthesiology, 2nd Affiliated Hospital of WenZhou Medical College, China.

出版信息

Anesthesiology. 2006 Jan;104(1):27-32. doi: 10.1097/00000542-200601000-00006.

DOI:10.1097/00000542-200601000-00006
PMID:16394686
Abstract

BACKGROUND

There is no information about the pharmacokinetic profile of propofol in Chinese children younger than 3 yr. This study was designed to determine a complete pharmacokinetic profile of a single dose of propofol in Chinese children of different ages.

METHODS

Arterial blood samples were obtained from 35 children with an American Society of Anesthesiologist physical status of I or II at 2, 4, 6, 8, 10, 20, 30, 45, 60, 90, 120, and 180 min after a single bolus intravenous injection of propofol (3 mg/kg). The plasma concentrations of propofol were measured using high-performance liquid chromatography with an ultraviolet detector. A population model was used to estimate the pharmacokinetics of propofol.

RESULTS

A three-compartment pharmacokinetic model best described the pharmacokinetics of propofol. Clearance was 0.185 l/min, the volume of distribution of the central compartment was 7.41 l, the peripheral volumes of distribution were 54.6 and 7.2 l, and the intercompartmental clearances were 0.614 and 0.692 l/min for a child of the average weight of 13.7 kg. The half-lives were 2.67, 14.89, and 310.60 min. Covariate models were applied, and weight was found to be significant covariate for the clearance and volume of distribution parameters. No significant age effect could be demonstrated on clearance or volume of distribution parameters after weight was taken into account.

CONCLUSIONS

This study supports the case that the pharmacokinetic properties of propofol do not differ substantially across Chinese children of different ages after weight has been accounted for.

摘要

背景

关于丙泊酚在中国3岁以下儿童中的药代动力学特征尚无相关信息。本研究旨在确定单剂量丙泊酚在中国不同年龄段儿童中的完整药代动力学特征。

方法

对35例美国麻醉医师协会身体状况分级为I或II级的儿童,单次静脉推注丙泊酚(3mg/kg)后,于2、4、6、8、10、20、30、45、60、90、120和180分钟采集动脉血样本。采用高效液相色谱-紫外检测器法测定丙泊酚的血浆浓度。使用群体模型估算丙泊酚的药代动力学。

结果

三室药代动力学模型能最好地描述丙泊酚的药代动力学。对于平均体重为13.7kg的儿童,清除率为0.185l/min,中央室分布容积为7.41l,外周分布容积分别为54.6l和7.2l,室间清除率分别为0.614l/min和0.692l/min。半衰期分别为2.67、14.89和310.60分钟。应用协变量模型,发现体重是清除率和分布容积参数的显著协变量。在考虑体重因素后,未发现年龄对清除率或分布容积参数有显著影响。

结论

本研究支持以下观点,即考虑体重因素后,丙泊酚在中国不同年龄段儿童中的药代动力学特性无显著差异。

相似文献

1
Pharmacokinetics of a single bolus of propofol in chinese children of different ages.不同年龄段中国儿童单次静脉注射丙泊酚的药代动力学
Anesthesiology. 2006 Jan;104(1):27-32. doi: 10.1097/00000542-200601000-00006.
2
Population pharmacokinetics of propofol: a multicenter study.丙泊酚的群体药代动力学:一项多中心研究。
Anesthesiology. 2000 Mar;92(3):727-38. doi: 10.1097/00000542-200003000-00017.
3
Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches.1 - 3岁轻度烧伤儿童单次注射异丙酚后的药代动力学。三种数据分析方法的比较。
Anesthesiology. 1996 Mar;84(3):526-32. doi: 10.1097/00000542-199603000-00006.
4
The pharmacokinetics of propofol in children using three different data analysis approaches.使用三种不同数据分析方法时丙泊酚在儿童体内的药代动力学。
Anesthesiology. 1994 Jan;80(1):104-22. doi: 10.1097/00000542-199401000-00018.
5
Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.大鼠、儿童和成人中丙泊酚药代动力学的异速生长关系。
Br J Clin Pharmacol. 2005 Jun;59(6):705-11. doi: 10.1111/j.1365-2125.2005.02239.x.
6
Population pharmacokinetics of propofol in Chinese patients.丙泊酚在中国患者中的群体药代动力学。
Acta Pharmacol Sin. 2003 Jun;24(6):581-8.
7
Pharmacokinetics of propofol in children.
Br J Anaesth. 1990 Nov;65(5):661-7. doi: 10.1093/bja/65.5.661.
8
Pharmacokinetics of propofol in patients undergoing total hip replacement : effect of acute hypervolemic hemodilution.全髋关节置换患者丙泊酚的药代动力学:急性高容量血液稀释的影响
Anaesthesist. 2011 Sep;60(9):835-40. doi: 10.1007/s00101-011-1907-y. Epub 2011 Jun 19.
9
Pharmacokinetics and clinical pharmacodynamics of the new propofol prodrug GPI 15715 in volunteers.新型丙泊酚前体药物GPI 15715在志愿者体内的药代动力学和临床药效学
Anesthesiology. 2003 Aug;99(2):303-13. doi: 10.1097/00000542-200308000-00012.
10
Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery.丙泊酚6%用于小儿心脏手术后短期镇静的药代动力学及效应
Br J Clin Pharmacol. 2002 Oct;54(4):415-22. doi: 10.1046/j.1365-2125.2002.01652.x.

引用本文的文献

1
Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints.青少年脊柱侧弯手术中术中唤醒试验时依托咪酯的群体药代动力学-药效学模型:以双频谱指数和复合听觉诱发电位为药效终点的研究。
BMC Anesthesiol. 2019 Jan 22;19(1):15. doi: 10.1186/s12871-019-0684-z.
2
The use of PBPK modeling across the pediatric age range using propofol as a case.以丙泊酚为例,在儿科年龄范围内使用 PBPK 模型。
J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):765-785. doi: 10.1007/s10928-018-9607-8. Epub 2018 Oct 8.
3
The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.
UDP-葡糖醛酸基转移酶酶的个体发生,未来分析研究的建议及通过生理基于药代动力学建模的应用。
Clin Pharmacokinet. 2019 Feb;58(2):189-211. doi: 10.1007/s40262-018-0681-2.
4
The effects of propofol on cerebral perfusion MRI in children.异丙酚对儿童脑灌注 MRI 的影响。
Neuroradiology. 2013 Aug;55(8):1049-1056. doi: 10.1007/s00234-013-1187-0. Epub 2013 May 15.
5
Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.丙泊酚药代动力学的体型或去脂体重标度:旨在简化靶控输注的参数集。
Clin Pharmacokinet. 2012 Mar 1;51(3):137-45. doi: 10.2165/11596980-000000000-00000.